Scott: And I've listened, Joe. So, what I'm saying is if

New Post Public Reply Private Reply Replies (0) Message Board
Msowid
289
Scott: And I've listened, Joe. So, what I'm saying is if you were to take--and just
hear me out, and if you don't want to do it, fine--if you were to take your
existing footprint on Excellagen, where you're approved to sell what you
think you're going to sell in 2020. If that number were a thousand vials of 3
cc at 5700 gross margin and you were to put out a PR Monday saying, "We
think our 2020 bare minimum Excellagen sales are going to be this," and
there was a number like a thousand of those at 5700 bucks gross margin, I'd
go out and celebrate--and a lot of other people would too.

Joe: Well, you know what companies do that? Are companies on the OTC that are a sham company, that typically do things like that. I cannot, in good
conscience, do anything like that unless I'm fully funded,
unless these
companies get the necessary dollars to fully execute on their plan or...
[crosstalk] Until that happens, I am not going to hypotheticalize on what
potential sales could be.

Scott: I'm not asking for hypotheticals. You are stocking your shelves with a
product, correct? You have said you have sales from Excellagen, correct?
You have that manufactured...

Joe: Again, as of right now, that would be very hard for me to gauge because I
don't... am I going to have--you tell me, am I going to have 20 VAs with the
money, am I going 50 VAs...?

Scott: That was what I'm saying, just tell us, "Worst case... here's what we’ve
gotten..."

Joe: I can't tell give that to you.
Scott: You don't have to tell me now, but if I have an asset that I'm producing for a
company that is not able to... where else are we producing revenues?

Joe: Listen, I appreciate what you're trying to make me do, but I'm not going to
hypotheticalize what we could do based upon so many different variables at
this point. I'd like to get the money in, full-funded, and then I'll project based
upon having all the money necessary to give you what you want in a forecast.
Scott: Okay. So, how long after we get the S-1 through do you think that would
happen, that we'd see something that says, "Here's what we're projecting."?
You've said that you think 250 million--
Joe: I don't know... it would be a guess. I don't know. How long will the STC take
to review the S-1 and then render it effective? I don't know.

Scott: No, I'm saying once you have the S-1, the 40 to 70 million is in the bank, do
you think that you'll put out a projection in X weeks, X months after...

Joe: If we are fully funded, I would out projections pretty immediately, because
then I know--I know already what it costs to get to... put $1 million in, get
$10 million out. I know what that is already. So, if I'm fully funded, then I'll
be able to forecast, but not until. And there's no way of me knowing yet if I'm
going to be fully-funded--I know I'll be funded, but I don't know if I'll be
fully funded.

Scott: Okay. So, after the S-1, whether it's fully funded or partially funded, you
intend to project out and say "Given the money that I have, here's what I
think would be."

Joe: That's what most public companies do when they have revenue, yeah. That's
typically the game plan.

Scott: Alright. Well, if you feel that anything is... the rubber has hit the road and
there's an announcement worthy of making, if this process takes longer than
you think, then we'd appreciate hearing that.

Joe: Well, listen, I'm sure we'll be having another conference call soon... and I've
never seen anyone do as many as we do... so, we're right at the end here.
We've got to get the S-1 filed as I'm saying, got to get funding; once we're
funded, then we turn on the pieces that we acquired with no money--or hardly
any money--and then away we go and build the enterprise and deliver the
going concern.

Scott: Alright. Well, thanks for your time, Joe. Good luck on that S-1 then, it sounds
like that's the--

Joe: Well, keep your eyes open, it should be filed within the next week or ten days
for sure. Done--I can tell you it's done, but filing it is a different story
sometimes.

Scott: Great. Thanks a lot, Joe.

Joe: Thank you very much.

I found this interaction to be the most poignant that joe was in.....as he was pressed to give projections of sales, that don't exist yet, and how he manuevered to NOT ANSWER the question, no matter what....

page 31-33 of conference call on the 29 th of Nov, 2019

Generex Biotechnology Corp. (GNBTQ) Stock Research Links

GNBTQ Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

NYSE Reflects on 9/11: Honoring Lives and Legacy

Updated Category News Views 7

A Somber Day at NYSE: Reflecting on 9/11 September 11th grips the heart of NYSE every year, but this year's 25th-anniversary powerfully reverberates through its hallowed halls. The hustle of the trading floor halts for a moment at 9:20 AM ET, paying homage to those lost in the harrowing attacks. I've seen the markets flap in the wind of countless crises, but nothing's...

Continue Reading
Sustainability Investments: $17 Trillion Wager Faces Divergence

Updated Category News Views 4

Sustainability Investments: A Tale of Contrasts In the world of sustainability, a staggering $17 trillion has been poured into technologies over the past decade. That’s no chump change. But what do we have to show for it? According to Bain & Company’s latest report, this massive financial injection hasn’t exactly hit a home run. Progress, much like the stock market...

Continue Reading
Oil Markets Shift Focus: Pipelines Trump Drilling

Updated Category News Views 8

Decoupling Oil Price and Production Response This oil market isn’t your usual rodeo. With Brent flirting with $100, it’s a seismic shift that’s not yielding new drills but redirecting capital to the existing infrastructure landscape. Ask yourself why we're not seeing the usual cavalry charge of new rigs. It’s simple: Pipeline mileage and producing wells have...

Continue Reading
Modeling and Mental Health Join Forces for Wellness

Updated Category News Views 4

A Fresh Alliance for Mental Wellness in Modeling Alright, let's shine a spotlight on a significant step in the modeling industry, a place typically less vocal about mental health. In a move that feels long overdue, Brain-Body Therapy and Mother Model Management have joined forces, marking the beginning of a collaborative effort to propel mental wellness to the forefront...

Continue Reading
Melissa Rivers Brings Her Wit Back to Emmys Carpet

Updated Category News Views 11

They say you can never go home again, but don't tell that to Melissa Rivers. Rolling the dice on nostalgia and kicking off a new chapter, she's waltzing back to the Emmys red carpet for the first time in nearly 20 years. Alright, what's in it for investors? Not much—unless you're looking to invest in nostalgia. But there's something here about legacy, reinvention, and...

Continue Reading
Intus Bio Secures $2.7M for Colorectal Cancer Test

Updated Category News Views 5

Pioneering Efforts in Early-Onset Colorectal Cancer Detection The battlefield of colorectal cancer prevention just got a serious upgrade with Intus Bio grabbing a $2.7 million award. This ain't just pocket change—it's a shot at rewriting the script on how we approach early-onset colorectal cancer, the pesky number one cancer gnawing at the under-50 crowd. Partnering...

Continue Reading
Lick the Plate Hits 2,000 Shows with Clown Band

Updated Category News Views 5

They say good things come in bizarre packages, and that's exactly the case as David Boylan's Lick the Plate zany celebration marks 15 years on air with its 2,000th episode. If you think of radio as a predictable endeavor, well, you're not tuned into Lick the Plate. A Milepost Draped in Multicolored Fabrics When you're browsing through colorful avenues of radio fame, it's...

Continue Reading
Jari Spirits Set to Shake Up U.S. Market After Big Wins

Updated Category News Views 4

Korean Spirits Jari Eyes U.S. Market Entry Some stories just have that perfect 'right time, right place' vibe, and CJ Foods' recent splash with their Korean spirits brand jari is one of them. Buckle up, because this one's about a Korean distilling sensation gearing up to hit American shores with a bang. Accolades Pave the Path Jari, the premium Korean distilled spirits...

Continue Reading
2026 Buy-Side Index Reveals State Market Variance

Updated Category News Views 6

Toss out your one-size-fits-all real estate predictions; the Q2 2026 Buy-Side Index just unveiled some real whoppers about the housing market. What we're seeing isn't your typical year-over-year growth across the board. Nope, we're seeing splits as sharp as a knife between states. Some places are shooting up in price, while others seem to be stuck in mud. Price Surges and...

Continue Reading
High-Grade Copper Spurs Optimism for PolarX in Alaska

Updated Category News Views 4

Copper's New Pulse: PolarX Makes Waves in Alaska Ever hear about striking copper so rich it's practically shimmering? Well, PolarX Limited just might have hit that sweet spot up in the rugged expanses of Alaska. Let me tell you, when you're knee-deep in resources, like what they’re discovering at the Caribou Dome Project, it sure feels like you’ve struck modern-day...

Continue Reading

Top 5 Most Recently Viewed Articles

Hawaiian Holdings Achieves Remarkable Stock Milestone

Updated Category News Views 54

Hawaiian Holdings Stock Hits New High In an impressive show of resilience, Hawaiian Holdings Inc. (NASDAQ: HA) has reached a remarkable 52-week high of $17.76. This achievement marks a significant rebound for the airline, reflecting a stock price that has more than doubled in the past year with a striking 124.97% increase. This week's peak indicates growing investor...

Continue Reading
Zebra Technologies Enhances Brand Engagement with PR Agency

Updated Category News Views 208

Zebra Technologies Partners with Ruder Finn to Boost Brand Presence Zebra Technologies Corporation, a frontrunner in digitizing and automating frontline workflows, has enlisted Ruder Finn as its public relations Agency of Record for the Americas. This strategic collaboration aims to elevate Zebra’s brand visibility while highlighting its transformative impact on...

Continue Reading
Infortar Expands Portfolio with Full Ownership of Subsidiary

Updated Category News Views 163

Infortar Strengthens Its Position in Real Estate Aktsiaselts Infortar has recently made a strategic move by acquiring a full ownership stake in OÜ INF Saue. This acquisition allows Infortar to consolidate its real estate operations, further broadening its scope and reach in the market. OÜ INF Saue was previously partially owned, with Infortar purchasing the remaining...

Continue Reading
Class Action Lawsuit Filed Against AppLovin Corporation Over Fraud Claims

Updated Category News Views 169

Class Action Lawsuit Filed Against AppLovin Corporation Pomerantz LLP has announced a significant class action lawsuit against AppLovin Corporation (NASDAQ: APP), focusing on serious allegations pertaining to securities fraud. Investors are encouraged to reach out to legal representatives if they have experienced financial losses due to their investments in AppLovin....

Continue Reading
Immunic, Inc. Experiences Market Trials Amidst Stock Low

Updated Category News Views 130

Stock Performance Overview Immunic, Inc. (NASDAQ: IMUX) has encountered turbulence in a competitive market, with its stock price dropping to a 52-week low of $0.97. This decline indicates a notable decrease in value compared to previous assessments, with a year-to-date change of -18.07%. Despite this downturn, the company holds a robust liquidity position, characterized...

Continue Reading